Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells

scientific article published on 30 October 2008

Degradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1182/BLOOD-2008-08-172742
P698PubMed publication ID18974372
P5875ResearchGate publication ID23441946

P50authorAtsushi OchiaiQ88335769
Genichiro IshiiQ88492973
Keiichi YanoQ90988987
Ayuko HoshinoQ116782120
Ta-Kashi ItoQ116782135
P2093author name stringSeiji Saito
Tasuku Suzuki
P433issue10
P407language of work or nameEnglishQ1860
P921main subjectendotheliumQ111140
P1104number of pages7
P304page(s)2363-2369
P577publication date2008-10-30
P1433published inBloodQ885070
P1476titleDegradation of soluble VEGF receptor-1 by MMP-7 allows VEGF access to endothelial cells
P478volume113

Reverse relations

cites work (P2860)
Q30439884A compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trap
Q27324767A computational model predicting disruption of blood vessel development
Q43104088Aqueous concentrations of VEGF and soluble VEGF receptor-1 in diabetic retinopathy patients
Q37987066Biomolecular predictors of urothelial cancer behavior and treatment outcomes
Q38170812Blood- and tissue-based biomarkers for prediction of outcomes in urothelial carcinoma of the bladder
Q26823757Corneal neovascularization and the utility of topical VEGF inhibition: ranibizumab (Lucentis) vs bevacizumab (Avastin)
Q47415825Dual roles of tumour cells-derived matrix metalloproteinase 2 on brain tumour growth and invasion.
Q46807078Elevated serum matrix metalloproteinase 7 levels predict poor prognosis after radical prostatectomy
Q35015402Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes
Q33769685Expression of circulating vascular endothelial growth factor-antagonizing cytokines and vascular stabilizing factors prior to and following bypass surgery in patients with moyamoya disease
Q27000351Extracellular regulation of VEGF: isoforms, proteolysis, and vascular patterning.
Q21202775Formation of VEGF isoform-specific spatial distributions governing angiogenesis: computational analysis
Q48144137Functional single nucleotide polymorphisms of matrix metalloproteinase 7 and 12 genes in idiopathic recurrent spontaneous abortion.
Q51557632Hypoxia paradoxically inhibits the angiogenic response of isolated vessel explants while inducing overexpression of vascular endothelial growth factor.
Q51363382In vivo monitoring of angiogenesis in a mouse hindlimb ischemia model using fluorescent peptide-based probes.
Q92462902Matrix metalloproteinase 7 in diagnosis and differentiation of pulmonary arterial hypertension
Q34199345Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
Q36960275Matrix metalloproteinases: inflammatory regulators of cell behaviors in vascular formation and remodeling
Q38520403Molecular markers in bladder cancer: Novel research frontiers
Q38871902Multidimensional Contribution of Matrix Metalloproteinases to Atherosclerotic Plaque Vulnerability: Multiple Mechanisms of Inhibition to Promote Stability
Q35991894Multivalent hyaluronic acid bioconjugates improve sFlt-1 activity in vitro
Q37480721Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor
Q60915925Overexpression of Notch3 is associated with metastasis and poor prognosis in osteosarcoma patients
Q34732281Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns
Q35083186Relationship between vitreous levels of matrix metalloproteinases and vascular endothelial growth factor in proliferative diabetic retinopathy
Q92541787Role of Matrix Metalloproteinases in Angiogenesis and Cancer
Q38224605Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression
Q35539470Serum Matrix Metalloproteinase-7 is an independent prognostic biomarker in advanced bladder cancer.
Q54630883Serum matrilysin correlates with poor survival independently of KRAS and BRAF status in refractory advanced colorectal cancer patients treated with irinotecan plus cetuximab.
Q34769889Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1
Q41487390The mechanisms of cerebral vascular dysfunction and neuroinflammation by MMP-mediated degradation of VEGFR-2 in alcohol ingestion
Q43289493Tyrosine sulphation of sphingosine 1-phosphate 1 (S1P1) is required for S1P-mediated cell migration in primary cultures of human umbilical vein endothelial cells
Q39797640VEGFR-2 silencing by small interference RNA (siRNA) suppresses LPA-induced epithelial ovarian cancer (EOC) invasion
Q43901283Validation of circulating MMP-7 level as an independent prognostic marker of poor survival in urinary bladder cancer
Q37767623Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis
Q28552652sFlt Multivalent Conjugates Inhibit Angiogenesis and Improve Half-Life In Vivo
Q35713784uPA and uPAR shRNA inhibit angiogenesis via enhanced secretion of SVEGFR1 independent of GM-CSF but dependent on TIMP-1 in endothelial and glioblastoma cells

Search more.